Carregant...
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018
Immunoglobulin light chain amyloidosis (AL) should be considered in any patient that presents to a cancer care provider with nephrotic range proteinuria, heart failure with preserved ejection fraction, non-diabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea. More importantly, patien...
Guardat en:
| Publicat a: | Blood Cancer J |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966459/ https://ncbi.nlm.nih.gov/pubmed/29795248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0080-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|